These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3592858)

  • 1. Perfluorochemical emulsion effect on warfarin binding by fraction V human albumin.
    Parsons DL
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):23-30. PubMed ID: 3592858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of warfarin by human albumin in the presence of a perfluorochemical blood substitute.
    Parsons DL; Ravis WR; Clark CR
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):4-14. PubMed ID: 4062432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a perfluorochemical emulsion on L-tryptophan binding by human albumin.
    Sathe RS; Parsons DL
    Arch Int Pharmacodyn Ther; 1990; 304():34-43. PubMed ID: 2241417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salicylate binding by human albumin in the presence of a perfluorochemical emulsion.
    Parsons DL; Sathe RS
    Arch Int Pharmacodyn Ther; 1991; 310():5-12. PubMed ID: 1772331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human albumin and alpha 1-acid glycoprotein binding of propranolol in the presence of a perfluorochemical blood substitute.
    Parsons DL; Shih RL
    Arch Int Pharmacodyn Ther; 1989; 297():294-304. PubMed ID: 2730240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of perfluorochemical emulsion components on human albumin binding of warfarin.
    Parsons DL; Nadkarni SR
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):165-74. PubMed ID: 3675079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfluorochemical emulsion effect on human albumin binding of valproic acid.
    Parsons DL; Ravis WR; Huang HC
    Res Commun Chem Pathol Pharmacol; 1991 Aug; 73(2):245-8. PubMed ID: 1784838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a perfluorochemical blood substitute on diazepam binding by human albumin.
    Graben RD; Parsons DL
    J Pharm Pharmacol; 1988 Oct; 40(10):684-8. PubMed ID: 2907533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human albumin binding of tamoxifen in the presence of a perfluorochemical erythrocyte substitute.
    Shah IG; Parsons DL
    J Pharm Pharmacol; 1991 Nov; 43(11):790-3. PubMed ID: 1686908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfluorochemical erythrocyte substitutes: disposition and effects on drug distribution and elimination.
    Ravis WR; Hoke JF; Parsons DL
    Drug Metab Rev; 1991; 23(3-4):375-411. PubMed ID: 1935577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of urapidil to human serum albumin: dependency on free fatty acid concentration.
    Storck J; Kirsten R
    Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):204-8. PubMed ID: 2071271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin.
    Wosilait WD; Ryan MP
    Res Commun Chem Pathol Pharmacol; 1979 Sep; 25(3):577-84. PubMed ID: 504792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
    Chan E; McLachlan AJ; Rowland M
    Chirality; 1993; 5(8):610-5. PubMed ID: 8305289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intersubject variation of warfarin binding to protein in serum of normal subjects.
    Yacobi A; Stoll RG; DiSanto AR; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):743-6. PubMed ID: 959669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of warfarin with human serum albumin. A stoichiometric description.
    Larsen FG; Larsen CG; Jakobsen P; Brodersen R
    Mol Pharmacol; 1985 Feb; 27(2):263-70. PubMed ID: 3969070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HSA affinity of warfarin and flurbiprofen determined by fluorescence anisotropy measurements of camptothecin.
    Wybranowski T; Cyrankiewicz M; Ziomkowska B; Kruszewski S
    Biosystems; 2008 Dec; 94(3):258-62. PubMed ID: 18721856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.